AssetMark Inc’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
BPC
AWA
HCM
BPCE
RG
HWAM
SBCM
PCM
AssetMark Inc's SOPH Position: Q2 2026 in Review
AssetMark Inc increased its SOPHiA GENETICS (SOPH) stake by 88% in Q2 2026, buying an estimated $20.9K and bringing the position to 8,836 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1828.
AssetMark Inc first reported a position in SOPH in Q1 2022 and has held it in 18 quarters since. 16 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- AssetMark Inc held 8,836 shares of SOPHiA GENETICS worth $51K as of Q2 2026.
- AssetMark Inc bought 4,125 SOPHiA GENETICS shares in Q2 2026, an estimated $20.9K.
- SOPHiA GENETICS made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1828 holding.
- AssetMark Inc first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 18 quarters since.
- 16 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.